| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Schizophrenia | 21 | 2021 | 1018 | 5.03 | Why? |
| Depressive Disorder | 16 | 2020 | 1236 | 4.12 | Why? |
| Schizophrenic Psychology | 11 | 2018 | 198 | 3.51 | Why? |
| Electroconvulsive Therapy | 5 | 2021 | 326 | 2.63 | Why? |
| Compulsive Behavior | 4 | 2017 | 53 | 2.13 | Why? |
| Psychiatric Status Rating Scales | 7 | 2018 | 1340 | 1.99 | Why? |
| Bipolar Disorder | 7 | 2019 | 744 | 1.82 | Why? |
| Obsessive Behavior | 3 | 2017 | 44 | 1.54 | Why? |
| Catatonia | 3 | 2021 | 102 | 1.52 | Why? |
| Depressive Disorder, Treatment-Resistant | 2 | 2018 | 99 | 1.30 | Why? |
| India | 30 | 2021 | 11875 | 1.28 | Why? |
| Mood Disorders | 3 | 2019 | 431 | 1.21 | Why? |
| Social Stigma | 3 | 2020 | 1049 | 1.15 | Why? |
| Mendelian Randomization Analysis | 2 | 2018 | 317 | 1.15 | Why? |
| Clozapine | 2 | 2020 | 218 | 1.14 | Why? |
| Depression | 13 | 2021 | 14116 | 1.10 | Why? |
| Antidepressive Agents | 7 | 2018 | 509 | 1.10 | Why? |
| Attention Deficit Disorder with Hyperactivity | 3 | 2019 | 441 | 1.06 | Why? |
| Antipsychotic Agents | 5 | 2020 | 887 | 1.04 | Why? |
| Obsessive-Compulsive Disorder | 4 | 2018 | 486 | 1.02 | Why? |
| Stress, Psychological | 7 | 2020 | 10231 | 0.94 | Why? |
| Behavior, Addictive | 2 | 2019 | 535 | 0.89 | Why? |
| Alcoholism | 2 | 2021 | 691 | 0.87 | Why? |
| Psychotic Disorders | 2 | 2021 | 924 | 0.82 | Why? |
| Somatoform Disorders | 2 | 2020 | 153 | 0.81 | Why? |
| Panic Disorder | 1 | 2020 | 84 | 0.77 | Why? |
| Social Marginalization | 1 | 2020 | 115 | 0.76 | Why? |
| Pica | 1 | 2018 | 2 | 0.74 | Why? |
| Survivorship | 1 | 2020 | 106 | 0.74 | Why? |
| Depressive Disorder, Major | 3 | 2018 | 852 | 0.74 | Why? |
| Factor Analysis, Statistical | 5 | 2018 | 538 | 0.73 | Why? |
| Tobacco Use Disorder | 1 | 2021 | 163 | 0.73 | Why? |
| Dry Powder Inhalers | 1 | 2018 | 36 | 0.73 | Why? |
| Suicide, Attempted | 3 | 2021 | 599 | 0.72 | Why? |
| Mutism | 1 | 2017 | 2 | 0.71 | Why? |
| Patient Dropouts | 1 | 2018 | 96 | 0.71 | Why? |
| Psychiatry | 2 | 2020 | 1289 | 0.70 | Why? |
| Metered Dose Inhalers | 1 | 2018 | 46 | 0.69 | Why? |
| Psychosocial Support Systems | 2 | 2020 | 710 | 0.67 | Why? |
| Anxiety Disorders | 4 | 2018 | 2290 | 0.66 | Why? |
| Social Perception | 2 | 2020 | 371 | 0.66 | Why? |
| Cognitive Dysfunction | 3 | 2018 | 1389 | 0.65 | Why? |
| Social Discrimination | 1 | 2020 | 269 | 0.64 | Why? |
| Ketamine | 1 | 2018 | 112 | 0.64 | Why? |
| Executive Function | 1 | 2018 | 173 | 0.63 | Why? |
| Benzodiazepines | 1 | 2018 | 163 | 0.62 | Why? |
| Parents | 3 | 2020 | 2758 | 0.61 | Why? |
| Affective Symptoms | 1 | 2017 | 160 | 0.60 | Why? |
| Sexual Dysfunction, Physiological | 1 | 2016 | 89 | 0.59 | Why? |
| Anxiety | 6 | 2021 | 17311 | 0.59 | Why? |
| Causality | 2 | 2018 | 857 | 0.58 | Why? |
| Patient Acceptance of Health Care | 3 | 2019 | 5002 | 0.58 | Why? |
| Sexual Health | 1 | 2020 | 419 | 0.57 | Why? |
| Checklist | 3 | 2017 | 714 | 0.56 | Why? |
| Patient Satisfaction | 2 | 2018 | 2517 | 0.56 | Why? |
| Mental Health Services | 4 | 2020 | 3007 | 0.55 | Why? |
| Fertility | 1 | 2018 | 367 | 0.55 | Why? |
| Cognition | 3 | 2021 | 1394 | 0.54 | Why? |
| Telephone | 2 | 2020 | 1705 | 0.54 | Why? |
| Adult | 53 | 2021 | 244371 | 0.53 | Why? |
| Accidental Falls | 1 | 2018 | 448 | 0.53 | Why? |
| Sexual Behavior | 2 | 2020 | 1322 | 0.53 | Why? |
| Health Knowledge, Attitudes, Practice | 4 | 2020 | 8811 | 0.53 | Why? |
| Sex Characteristics | 2 | 2018 | 1120 | 0.52 | Why? |
| Awareness | 1 | 2018 | 529 | 0.51 | Why? |
| Female | 64 | 2021 | 380317 | 0.51 | Why? |
| Psychiatric Department, Hospital | 1 | 2017 | 253 | 0.50 | Why? |
| Caregivers | 2 | 2019 | 3112 | 0.50 | Why? |
| Patient Preference | 1 | 2020 | 750 | 0.50 | Why? |
| Geriatric Assessment | 2 | 2018 | 1372 | 0.49 | Why? |
| Psychometrics | 2 | 2017 | 1269 | 0.48 | Why? |
| Neurodegenerative Diseases | 1 | 2018 | 469 | 0.47 | Why? |
| Environment | 1 | 2018 | 769 | 0.47 | Why? |
| Mental Disorders | 3 | 2020 | 6742 | 0.47 | Why? |
| Male | 61 | 2021 | 367725 | 0.47 | Why? |
| Metabolic Syndrome | 2 | 2017 | 810 | 0.47 | Why? |
| Drug Monitoring | 1 | 2020 | 1408 | 0.46 | Why? |
| Cross-Sectional Studies | 20 | 2021 | 53120 | 0.44 | Why? |
| Cell Phone | 1 | 2019 | 750 | 0.44 | Why? |
| Delayed Diagnosis | 1 | 2021 | 1529 | 0.43 | Why? |
| Humans | 84 | 2021 | 930598 | 0.42 | Why? |
| Internet | 2 | 2019 | 6204 | 0.42 | Why? |
| Health Literacy | 1 | 2020 | 1078 | 0.40 | Why? |
| Prevalence | 11 | 2021 | 25773 | 0.40 | Why? |
| Child Health | 1 | 2019 | 940 | 0.40 | Why? |
| Anger | 2 | 2020 | 123 | 0.40 | Why? |
| Personnel, Hospital | 2 | 2020 | 2273 | 0.40 | Why? |
| Breast Feeding | 1 | 2020 | 1585 | 0.39 | Why? |
| Young Adult | 24 | 2021 | 93724 | 0.38 | Why? |
| Physicians | 2 | 2019 | 4214 | 0.38 | Why? |
| Rural Population | 2 | 2019 | 2408 | 0.38 | Why? |
| Delirium | 1 | 2019 | 1061 | 0.37 | Why? |
| Spouses | 2 | 2020 | 131 | 0.37 | Why? |
| Middle Aged | 39 | 2021 | 270681 | 0.36 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.36 | Why? |
| Activities of Daily Living | 1 | 2017 | 1530 | 0.35 | Why? |
| Family Characteristics | 1 | 2018 | 2551 | 0.35 | Why? |
| Transients and Migrants | 1 | 2020 | 1468 | 0.35 | Why? |
| Survivors | 1 | 2020 | 2619 | 0.35 | Why? |
| Age of Onset | 3 | 2018 | 557 | 0.34 | Why? |
| Internship and Residency | 2 | 2019 | 4987 | 0.34 | Why? |
| Antimanic Agents | 2 | 2018 | 54 | 0.34 | Why? |
| Adaptation, Psychological | 4 | 2020 | 4996 | 0.34 | Why? |
| Substance-Related Disorders | 2 | 2018 | 2038 | 0.34 | Why? |
| Psychotropic Drugs | 4 | 2020 | 396 | 0.33 | Why? |
| Surveys and Questionnaires | 12 | 2020 | 43792 | 0.32 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.32 | Why? |
| Tertiary Care Centers | 7 | 2021 | 8248 | 0.32 | Why? |
| Suicidal Ideation | 3 | 2021 | 1226 | 0.32 | Why? |
| Adolescent | 19 | 2021 | 86841 | 0.31 | Why? |
| Nepal | 2 | 2020 | 1004 | 0.30 | Why? |
| Health Promotion | 1 | 2019 | 2020 | 0.30 | Why? |
| Hospitalization | 4 | 2020 | 54280 | 0.30 | Why? |
| Health Personnel | 3 | 2020 | 29646 | 0.30 | Why? |
| Drug Prescriptions | 4 | 2018 | 1062 | 0.30 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.29 | Why? |
| Comorbidity | 12 | 2019 | 34796 | 0.29 | Why? |
| Quarantine | 4 | 2020 | 18418 | 0.28 | Why? |
| Health Surveys | 3 | 2020 | 2841 | 0.28 | Why? |
| Disability Evaluation | 2 | 2017 | 671 | 0.25 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2019 | 2963 | 0.24 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.23 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.22 | Why? |
| Fear | 3 | 2021 | 3607 | 0.22 | Why? |
| Linear Models | 2 | 2018 | 1914 | 0.22 | Why? |
| Ambulatory Care | 1 | 2018 | 4947 | 0.21 | Why? |
| Biomedical Research | 1 | 2021 | 5270 | 0.21 | Why? |
| Attitude of Health Personnel | 1 | 2019 | 4741 | 0.21 | Why? |
| Irritable Mood | 1 | 2020 | 93 | 0.21 | Why? |
| Students | 1 | 2019 | 5255 | 0.21 | Why? |
| Genome-Wide Association Study | 2 | 2018 | 1648 | 0.21 | Why? |
| Guilt | 1 | 2020 | 74 | 0.20 | Why? |
| Shame | 1 | 2020 | 53 | 0.20 | Why? |
| Pandemics | 12 | 2021 | 389249 | 0.20 | Why? |
| Psychoses, Substance-Induced | 1 | 2020 | 91 | 0.20 | Why? |
| Education, Distance | 1 | 2020 | 4956 | 0.19 | Why? |
| Hypertension | 2 | 2018 | 8895 | 0.19 | Why? |
| Interleukin-11 | 1 | 2018 | 8 | 0.19 | Why? |
| Agoraphobia | 1 | 2018 | 3 | 0.19 | Why? |
| Polypharmacy | 2 | 2020 | 347 | 0.19 | Why? |
| Aged | 19 | 2020 | 215776 | 0.19 | Why? |
| Hirschsprung Disease | 1 | 2018 | 7 | 0.19 | Why? |
| Adjustment Disorders | 1 | 2020 | 66 | 0.19 | Why? |
| Education, Nonprofessional | 1 | 2019 | 31 | 0.19 | Why? |
| Asthma | 1 | 2018 | 4383 | 0.19 | Why? |
| Emotional Adjustment | 1 | 2020 | 127 | 0.19 | Why? |
| Bullying | 1 | 2020 | 98 | 0.19 | Why? |
| Recurrence | 2 | 2020 | 3675 | 0.19 | Why? |
| Mentally Ill Persons | 1 | 2020 | 103 | 0.19 | Why? |
| Neuroticism | 1 | 2019 | 87 | 0.19 | Why? |
| Telemedicine | 2 | 2020 | 25032 | 0.19 | Why? |
| Ice | 1 | 2018 | 10 | 0.18 | Why? |
| Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2018 | 15 | 0.18 | Why? |
| Aggression | 1 | 2019 | 126 | 0.18 | Why? |
| Brief Psychiatric Rating Scale | 1 | 2017 | 30 | 0.18 | Why? |
| Marijuana Smoking | 1 | 2019 | 80 | 0.18 | Why? |
| Marriage | 1 | 2018 | 83 | 0.18 | Why? |
| Defense Mechanisms | 1 | 2017 | 30 | 0.18 | Why? |
| Longitudinal Studies | 3 | 2018 | 9893 | 0.18 | Why? |
| Life Change Events | 1 | 2020 | 208 | 0.18 | Why? |
| Ranibizumab | 1 | 2018 | 103 | 0.18 | Why? |
| Psychotherapy, Group | 1 | 2019 | 134 | 0.18 | Why? |
| Social Conditions | 1 | 2020 | 196 | 0.17 | Why? |
| Vertigo | 1 | 2018 | 141 | 0.17 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.17 | Why? |
| Quality of Life | 2 | 2018 | 9820 | 0.17 | Why? |
| Hope | 1 | 2020 | 210 | 0.17 | Why? |
| Genetic Pleiotropy | 1 | 2017 | 13 | 0.17 | Why? |
| Birth Rate | 1 | 2018 | 137 | 0.17 | Why? |
| Transcranial Magnetic Stimulation | 1 | 2018 | 160 | 0.16 | Why? |
| Videoconferencing | 2 | 2020 | 2081 | 0.16 | Why? |
| Prefrontal Cortex | 1 | 2018 | 151 | 0.16 | Why? |
| Apolipoprotein E4 | 1 | 2017 | 99 | 0.16 | Why? |
| Psychopathology | 1 | 2017 | 107 | 0.16 | Why? |
| Macular Edema | 1 | 2018 | 139 | 0.16 | Why? |
| Linkage Disequilibrium | 1 | 2017 | 191 | 0.16 | Why? |
| Least-Squares Analysis | 1 | 2017 | 254 | 0.16 | Why? |
| Serotonin Uptake Inhibitors | 1 | 2018 | 149 | 0.16 | Why? |
| Child Behavior | 1 | 2019 | 266 | 0.15 | Why? |
| Optical Imaging | 1 | 2017 | 197 | 0.15 | Why? |
| Qualitative Research | 2 | 2018 | 4337 | 0.15 | Why? |
| Professional-Patient Relations | 1 | 2020 | 426 | 0.15 | Why? |
| Cannabis | 1 | 2019 | 284 | 0.14 | Why? |
| Hearing Loss | 1 | 2018 | 225 | 0.14 | Why? |
| Health Services Accessibility | 1 | 2019 | 10697 | 0.14 | Why? |
| Speech | 1 | 2017 | 241 | 0.14 | Why? |
| Blood Glucose Self-Monitoring | 1 | 2020 | 791 | 0.14 | Why? |
| Diagnosis, Differential | 2 | 2021 | 7220 | 0.14 | Why? |
| Family Health | 1 | 2020 | 731 | 0.14 | Why? |
| Spirometry | 1 | 2018 | 524 | 0.14 | Why? |
| Angiogenesis Inhibitors | 1 | 2018 | 395 | 0.14 | Why? |
| Promoter Regions, Genetic | 1 | 2018 | 823 | 0.14 | Why? |
| Models, Genetic | 1 | 2017 | 434 | 0.14 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.14 | Why? |
| Child | 8 | 2020 | 70012 | 0.14 | Why? |
| Likelihood Functions | 1 | 2017 | 719 | 0.13 | Why? |
| Counseling | 1 | 2020 | 747 | 0.13 | Why? |
| Pediatric Obesity | 1 | 2019 | 492 | 0.13 | Why? |
| Fluorescein Angiography | 1 | 2017 | 426 | 0.13 | Why? |
| Administration, Intranasal | 1 | 2018 | 1132 | 0.13 | Why? |
| Diabetic Retinopathy | 1 | 2018 | 347 | 0.13 | Why? |
| Bibliometrics | 1 | 2021 | 731 | 0.13 | Why? |
| Asia | 5 | 2019 | 2399 | 0.13 | Why? |
| Parenting | 1 | 2019 | 486 | 0.13 | Why? |
| Symptom Assessment | 2 | 2017 | 4967 | 0.13 | Why? |
| Remission Induction | 1 | 2017 | 950 | 0.13 | Why? |
| Outpatient Clinics, Hospital | 1 | 2018 | 523 | 0.12 | Why? |
| Anticonvulsants | 1 | 2018 | 634 | 0.12 | Why? |
| Polymorphism, Single Nucleotide | 3 | 2018 | 3607 | 0.12 | Why? |
| Schools | 2 | 2019 | 4187 | 0.12 | Why? |
| Social Isolation | 3 | 2020 | 5932 | 0.11 | Why? |
| Retinal Diseases | 1 | 2017 | 441 | 0.11 | Why? |
| Hospitals, General | 1 | 2017 | 711 | 0.11 | Why? |
| Administration, Inhalation | 1 | 2018 | 1647 | 0.11 | Why? |
| Iron | 1 | 2017 | 619 | 0.11 | Why? |
| Hospitals, Psychiatric | 1 | 2017 | 506 | 0.11 | Why? |
| Insulin | 1 | 2020 | 1316 | 0.11 | Why? |
| Ethanol | 1 | 2016 | 533 | 0.11 | Why? |
| Risk Factors | 6 | 2020 | 71621 | 0.11 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.11 | Why? |
| Medical Staff, Hospital | 1 | 2021 | 1258 | 0.10 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.10 | Why? |
| Anesthesia | 1 | 2021 | 1236 | 0.10 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.10 | Why? |
| Fatigue | 1 | 2021 | 2479 | 0.10 | Why? |
| Religion and Psychology | 1 | 2011 | 55 | 0.10 | Why? |
| Catechol O-Methyltransferase | 1 | 2009 | 25 | 0.10 | Why? |
| Tomography, Optical Coherence | 1 | 2017 | 1008 | 0.10 | Why? |
| Risperidone | 1 | 2009 | 55 | 0.10 | Why? |
| Personal Satisfaction | 1 | 2018 | 1243 | 0.10 | Why? |
| Self Report | 1 | 2021 | 3802 | 0.10 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.09 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.09 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.09 | Why? |
| Social Class | 1 | 2017 | 1360 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.09 | Why? |
| Poverty | 1 | 2020 | 2302 | 0.09 | Why? |
| Spirituality | 1 | 2011 | 228 | 0.09 | Why? |
| Mothers | 1 | 2018 | 1624 | 0.09 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.08 | Why? |
| Emotions | 2 | 2017 | 2418 | 0.08 | Why? |
| Oxygen | 1 | 2021 | 3715 | 0.08 | Why? |
| Social Support | 2 | 2019 | 3183 | 0.08 | Why? |
| Alzheimer Disease | 1 | 2017 | 1020 | 0.08 | Why? |
| Drug Therapy, Combination | 2 | 2018 | 7268 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Arrhythmias, Cardiac | 1 | 2020 | 2510 | 0.08 | Why? |
| Child, Preschool | 3 | 2019 | 36283 | 0.08 | Why? |
| Cost of Illness | 1 | 2017 | 1903 | 0.08 | Why? |
| Epilepsy | 1 | 2018 | 1401 | 0.08 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2020 | 1969 | 0.08 | Why? |
| Occupational Diseases | 1 | 2021 | 2787 | 0.07 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.07 | Why? |
| Software | 1 | 2017 | 2501 | 0.07 | Why? |
| Referral and Consultation | 1 | 2020 | 4816 | 0.07 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.06 | Why? |
| Retrospective Studies | 4 | 2018 | 105322 | 0.06 | Why? |
| Aged, 80 and over | 5 | 2019 | 88759 | 0.06 | Why? |
| Burnout, Professional | 1 | 2018 | 2489 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.06 | Why? |
| Health Behavior | 1 | 2019 | 4449 | 0.05 | Why? |
| Inpatients | 1 | 2017 | 5161 | 0.05 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.05 | Why? |
| Severity of Illness Index | 3 | 2017 | 48226 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.05 | Why? |
| Proto-Oncogene Proteins c-ret | 1 | 2018 | 15 | 0.05 | Why? |
| Hoarding Disorder | 1 | 2018 | 4 | 0.05 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.05 | Why? |
| Socioeconomic Factors | 1 | 2017 | 8495 | 0.05 | Why? |
| Exercise | 1 | 2019 | 6771 | 0.05 | Why? |
| Personal Protective Equipment | 2 | 2021 | 15978 | 0.05 | Why? |
| Gene Frequency | 2 | 2017 | 1210 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 9706 | 0.04 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.04 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Retinal Ganglion Cells | 1 | 2017 | 80 | 0.04 | Why? |
| Proof of Concept Study | 1 | 2019 | 696 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Intravitreal Injections | 1 | 2018 | 347 | 0.04 | Why? |
| Infant | 1 | 2019 | 30274 | 0.04 | Why? |
| Waist Circumference | 1 | 2017 | 199 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Semen | 1 | 2021 | 550 | 0.04 | Why? |
| Organizational Policy | 1 | 2021 | 694 | 0.04 | Why? |
| Lipoproteins, HDL | 1 | 2017 | 154 | 0.04 | Why? |
| ErbB Receptors | 1 | 2017 | 320 | 0.04 | Why? |
| Models, Organizational | 1 | 2021 | 908 | 0.04 | Why? |
| Capillaries | 1 | 2017 | 257 | 0.04 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2018 | 604 | 0.03 | Why? |
| Retinal Vessels | 1 | 2017 | 255 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.03 | Why? |
| United States | 1 | 2021 | 46150 | 0.03 | Why? |
| Triglycerides | 1 | 2017 | 478 | 0.03 | Why? |
| Copper | 1 | 2017 | 288 | 0.03 | Why? |
| Mental Health | 1 | 2020 | 15770 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Logistic Models | 2 | 2019 | 9089 | 0.03 | Why? |
| Drug Interactions | 1 | 2020 | 1653 | 0.03 | Why? |
| Neuropsychological Tests | 1 | 2018 | 954 | 0.03 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.03 | Why? |
| Case-Control Studies | 3 | 2018 | 17671 | 0.03 | Why? |
| Visual Acuity | 1 | 2018 | 790 | 0.03 | Why? |
| Intestines | 1 | 2018 | 817 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.03 | Why? |
| Risk Assessment | 3 | 2021 | 25439 | 0.03 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.03 | Why? |
| Educational Status | 1 | 2017 | 1451 | 0.03 | Why? |
| Cerebrovascular Disorders | 1 | 2018 | 1040 | 0.03 | Why? |
| DiGeorge Syndrome | 1 | 2009 | 15 | 0.02 | Why? |
| Zinc | 1 | 2017 | 817 | 0.02 | Why? |
| Seizures | 1 | 2018 | 1163 | 0.02 | Why? |
| Lung | 1 | 2018 | 31049 | 0.02 | Why? |
| Health Education | 1 | 2020 | 1539 | 0.02 | Why? |
| Hospitals, University | 1 | 2021 | 4173 | 0.02 | Why? |
| Genetic Markers | 1 | 2009 | 318 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2020 | 2165 | 0.02 | Why? |
| Odds Ratio | 1 | 2019 | 5861 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Pilot Projects | 1 | 2019 | 5182 | 0.02 | Why? |
| Reference Values | 1 | 2009 | 795 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Age Factors | 2 | 2017 | 21039 | 0.02 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.02 | Why? |
| Developing Countries | 1 | 2021 | 4283 | 0.02 | Why? |
| Sequence Deletion | 1 | 2009 | 674 | 0.02 | Why? |
| Residence Characteristics | 1 | 2015 | 1927 | 0.02 | Why? |
| Cognition Disorders | 1 | 2009 | 574 | 0.02 | Why? |
| Sleep Initiation and Maintenance Disorders | 1 | 2015 | 1692 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.01 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |